 <h1>Levoxyl Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>levothyroxine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about levothyroxine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Levoxyl.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to levothyroxine: oral capsule liquid filled, oral solution, oral tablet</i></p><p>Other dosage forms:</p><ul><li>injection powder for solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule; Tablet; Solution)</p><p>Thyroid hormones, including levothyroxine, should not be used either alone or with other therapeutic agents for the treatment of obesity or weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, levothyroxine (the active ingredient contained in Levoxyl) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking levothyroxine:</p><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>decreased urine output</li>
<li>difficult or labored breathing</li>
<li>difficulty with swallowing</li>
<li>dilated neck veins</li>
<li>extreme fatigue</li>
<li>fainting</li>
<li>fast, slow, irregular, pounding, or racing heartbeat or pulse</li>
<li>fever</li>
<li>heat intolerance</li>
<li>hives or welts, skin itching, rash, or redness</li>
<li>irregular breathing</li>
<li>irritability</li>
<li>menstrual changes</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>sweating</li>
<li>swelling of the eyes, face, lips, throat, or tongue</li>
<li>tightness in the chest</li>
<li>tremors</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blurred or double vision</li>
<li>dizziness</li>
<li>eye pain</li>
<li>lack or slowing of normal growth in children</li>
<li>limp or walk favoring one leg</li>
<li>pain in the hip or knee</li>
<li>seizures</li>
<li>severe headache</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking levothyroxine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Change in consciousness</li>
<li>cold, clammy skin</li>
<li>confusion</li>
<li>disorientation</li>
<li>fast or weak pulse</li>
<li>lightheadedness</li>
<li>loss of consciousness</li>
<li>sudden headache</li>
<li>sudden loss of coordination</li>
<li>sudden slurring of speech</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of levothyroxine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>change in appetite</li>
<li>crying</li>
<li>diarrhea</li>
<li>false or unusual sense of well-being</li>
<li>fear or nervousness</li>
<li>feeling not well or unhappy</li>
<li>feeling of discomfort</li>
<li>feeling of warmth</li>
<li>feeling things are not real</li>
<li>feelings of suspicion and distrust</li>
<li>hair loss</li>
<li>headache</li>
<li>increased appetite</li>
<li>mental depression</li>
<li>muscle weakness</li>
<li>quick to react or overreact emotionally</li>
<li>rapidly changing moods</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>restlessness</li>
<li>trouble getting pregnant</li>
<li>trouble sitting still</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>weight gain or loss</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levothyroxine: compounding powder, injectable powder for injection, intravenous powder for injection, intravenous solution, oral capsule, oral solution, oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse events have included those of hyperthyroidism due to therapeutic overdose including arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.</p><h3>Cardiovascular</h3><p>Cardiac function was evaluated in 20 patients requiring TSH suppression for either thyroid goiter or following thyroidectomy and radioactive iodine therapy for thyroid cancer and in 20 age and sex-matched controls.  TSH suppression was associated with an increased incidence of premature ventricular beats, an increased left ventricular mass index, and enhanced left ventricular systolic function.  The clinical significance of these changes remains to be determined.</p>
<p></p>
<p>Overtreatment with this drug may cause an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias, particularly in patients with cardiovascular disease and in elderly patients.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Palpitations, tachycardia, hypertension, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Changes in symptom presentation for diabetes and adrenal cortical insufficiency<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Headache, hyperactivity, insomnia, seizures, pseudotumor cerebri (children)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Hair loss, flushing, urticaria, pruritus, skin rash, angioedema, excessive sweating<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Tremors, muscle weakness, muscle cramps, increased risk of osteoporosis, slipped capital femoral epiphysis (children)<sup>[Ref]</sup></p><p>A study evaluated the effect of long-term thyroid hormone therapy on bone mineral density in 196 women (mean age, 74.4 years) compared to a control group comprised of 795 women (mean age, 72.1 years).  The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years).  Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls.  However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density.</p>
<p></p>
<p>Higher rates of femur fractures have been found in males (p=0.008) prescribed long-term thyroid hormone therapy as compared to controls in a case-control analysis of 23,183 patients, from the United Kingdom General Practice Research Database, prescribed thyroid hormone.</p>
<p></p>
<p>Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Diarrhea, vomiting, abdominal cramps<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Menstrual irregularities, impaired fertility<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Serum sickness, hypersensitivity to inactive ingredients<sup>[Ref]</sup></p><p>Hypersensitivity reactions have occurred; however, it has been attributed to the inactive ingredients.  These reactions have included urticaria, pruritus, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing.  Hypersensitivity to levothyroxine itself is not known to occur.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased appetite, weight loss<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Autoimmune disorders (e.g., chronic autoimmune thyroiditis)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Fatigue, heat intolerance, fever<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Nervousness, anxiety, irritability, emotional lability<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Petersen K, Bengtason C, Lapidus L, et al "Morbidity, mortality, and quality of life for patients treated with levothyroxine." Arch Intern Med 150 (1990): 2077-81</p><p id="ref_3">3. "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. Sheppard MC,  Holder R,  Franklyn JA "Levothyroxine treatment and occurrence of fracture of the hip." Arch Intern Med 162 (2002): 338-43</p><p id="ref_6">6. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC "Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH." Clin Endocrinol (Oxf) 37 (1992): 500-3</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Effect of not taking medicine after thyroid removal?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Levoxyl (levothyroxine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>35 Reviews</li>
<li>Drug class: thyroid drugs</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Levoxyl &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Synthroid, Tirosint, Euthyrox, Levothroid, ... +2 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hashimoto's disease</li>
<li>Underactive Thyroid</li>
<li>Thyroid Suppression Test</li>
<li>Hypothyroidism, After Thyroid Removal</li>
<li>Myxedema Coma</li>
<li>TSH Suppression</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levothyroxine: compounding powder, injectable powder for injection, intravenous powder for injection, intravenous solution, oral capsule, oral solution, oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse events have included those of hyperthyroidism due to therapeutic overdose including arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.</p><h3>Cardiovascular</h3><p>Cardiac function was evaluated in 20 patients requiring TSH suppression for either thyroid goiter or following thyroidectomy and radioactive iodine therapy for thyroid cancer and in 20 age and sex-matched controls.  TSH suppression was associated with an increased incidence of premature ventricular beats, an increased left ventricular mass index, and enhanced left ventricular systolic function.  The clinical significance of these changes remains to be determined.</p><p></p><p>Overtreatment with this drug may cause an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias, particularly in patients with cardiovascular disease and in elderly patients.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Palpitations, tachycardia, hypertension, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Changes in symptom presentation for diabetes and adrenal cortical insufficiency<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Headache, hyperactivity, insomnia, seizures, pseudotumor cerebri (children)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Hair loss, flushing, urticaria, pruritus, skin rash, angioedema, excessive sweating<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Tremors, muscle weakness, muscle cramps, increased risk of osteoporosis, slipped capital femoral epiphysis (children)<sup>[Ref]</sup></p><p>A study evaluated the effect of long-term thyroid hormone therapy on bone mineral density in 196 women (mean age, 74.4 years) compared to a control group comprised of 795 women (mean age, 72.1 years).  The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years).  Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls.  However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density.</p><p></p><p>Higher rates of femur fractures have been found in males (p=0.008) prescribed long-term thyroid hormone therapy as compared to controls in a case-control analysis of 23,183 patients, from the United Kingdom General Practice Research Database, prescribed thyroid hormone.</p><p></p><p>Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Diarrhea, vomiting, abdominal cramps<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Menstrual irregularities, impaired fertility<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Serum sickness, hypersensitivity to inactive ingredients<sup>[Ref]</sup></p><p>Hypersensitivity reactions have occurred; however, it has been attributed to the inactive ingredients.  These reactions have included urticaria, pruritus, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing.  Hypersensitivity to levothyroxine itself is not known to occur.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased appetite, weight loss<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Autoimmune disorders (e.g., chronic autoimmune thyroiditis)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Fatigue, heat intolerance, fever<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Nervousness, anxiety, irritability, emotional lability<sup>[Ref]</sup></p><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Petersen K, Bengtason C, Lapidus L, et al "Morbidity, mortality, and quality of life for patients treated with levothyroxine." Arch Intern Med 150 (1990): 2077-81</p><p id="ref_3">3. "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. Sheppard MC,  Holder R,  Franklyn JA "Levothyroxine treatment and occurrence of fracture of the hip." Arch Intern Med 162 (2002): 338-43</p><p id="ref_6">6. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC "Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH." Clin Endocrinol (Oxf) 37 (1992): 500-3</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Effect of not taking medicine after thyroid removal?</li>
</ul><h2>More about Levoxyl (levothyroxine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>35 Reviews</li>
<li>Drug class: thyroid drugs</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Levoxyl &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hashimoto's disease</li>
<li>Underactive Thyroid</li>
<li>Thyroid Suppression Test</li>
<li>Hypothyroidism, After Thyroid Removal</li>
<li>Myxedema Coma</li>
<li>TSH Suppression</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>